Suppr超能文献

血清视黄醇结合蛋白4在肥胖症或肥胖相关的2型糖尿病中并未升高,但在胃旁路术后体脂相应减少后会降低。

Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.

作者信息

Gómez-Ambrosi J, Rodríguez A, Catalán V, Ramírez B, Silva C, Rotellar F, Gil M J, Salvador J, Frühbeck G

机构信息

Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain.

出版信息

Clin Endocrinol (Oxf). 2008 Aug;69(2):208-15. doi: 10.1111/j.1365-2265.2007.03156.x. Epub 2007 Dec 10.

Abstract

OBJECTIVE

Controversy exists regarding the elevation of serum retinol-binding protein 4 (RBP4) in human obesity and type 2 diabetes mellitus (T2DM). In the present study, we have compared serum RBP4 in lean and obese patients with or without T2DM, and analysed the effect of weight loss on serum RBP4.

DESIGN

Forty-two Caucasian subjects were included in the study. Serum RBP4 was measured by ELISA and Western blot. In addition, serum RBP4 was measured in 21 morbidly obese patients before and after 4, 8 and 15 months of weight loss following Roux-en-Y gastric bypass (RYGBP).

RESULTS

No significant effect of either obesity or diabetes on serum RBP4 was observed. Serum RBP4 concentrations (measured by either ELISA or Western blot) did not correlate with body mass index (BMI), body fat or any indicator of glucose metabolism or insulin resistance. Weight loss following RYGBP did not modify serum RBP4 at 15 months (P = 0.472). However, the variations in serum RBP4 were significantly associated with the reduction in body fat (r = 0.48; P = 0.026). Patients loosing over 20% of fat mass (n = 11) showed significantly different RBP4 concentrations compared to those individuals exhibiting smaller adiposity reductions (n = 10) (-11.0 +/- 6.4 vs.+5.8 +/- 3.6 mg/l; P = 0.036). Furthermore, RBP4 levels were significantly reduced at 4 (P = 0.006) and 8 (P = 0.015) months only in those patients loosing over 20% of fat mass.

CONCLUSION

Serum RBP4 concentrations are not increased in obese patients with or without T2DM. A decrease in RBP4 levels was only observed after surgically induced weight loss accompanied by relevant reductions in body fat. RBP4 might be considered as a dynamic marker of negative energy balance being reduced during weight loss when a negative energy balance threshold is reached. Furthermore, RBP4 variation in the first month after RYGBP may be a predictor of weight loss success.

摘要

目的

关于血清视黄醇结合蛋白4(RBP4)在人类肥胖症和2型糖尿病(T2DM)中的升高存在争议。在本研究中,我们比较了有或无T2DM的瘦人和肥胖患者的血清RBP4,并分析了体重减轻对血清RBP4的影响。

设计

42名白种人受试者纳入本研究。采用酶联免疫吸附测定(ELISA)和蛋白质免疫印迹法检测血清RBP4。此外,对21例病态肥胖患者在接受Roux-en-Y胃旁路术(RYGBP)减肥4、8和15个月前后的血清RBP4进行检测。

结果

未观察到肥胖或糖尿病对血清RBP4有显著影响。血清RBP4浓度(通过ELISA或蛋白质免疫印迹法检测)与体重指数(BMI)、体脂或任何葡萄糖代谢或胰岛素抵抗指标均无相关性。RYGBP术后15个月体重减轻并未改变血清RBP4水平(P = 0.472)。然而,血清RBP4的变化与体脂减少显著相关(r = 0.48;P = 0.026)。与体脂减少较小的个体(n = 10)相比,体脂减少超过20%的患者(n = 11)的RBP4浓度有显著差异(-11.0±6.4 vs. +5.8±3.6 mg/l;P = 0.036)。此外,仅在体脂减少超过20%的患者中,血清RBP4水平在4个月(P = 0.006)和8个月(P = 0.015)时显著降低。

结论

有或无T2DM的肥胖患者血清RBP4浓度均未升高。仅在手术诱导体重减轻并伴有体脂相应减少后,才观察到RBP4水平降低。当达到负能量平衡阈值时,RBP4可被视为减肥期间负能量平衡降低的动态标志物。此外,RYGBP术后第一个月RBP4的变化可能是减肥成功的预测指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验